Cargando…

Biopsy and Mutation Detection Strategies in Non-Small Cell Lung Cancer

The emergence of new therapeutic agents for non-small cell lung cancer (NSCLC) implies that histologic subtyping and molecular predictive testing are now essential for therapeutic decisions. Histologic subtype predicts the efficacy and toxicity of some treatment agents, as do genetic alterations, wh...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jung, Chi Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861373/ https://www.ncbi.nlm.nih.gov/pubmed/24348665 http://dx.doi.org/10.4046/trd.2013.75.5.181

Ejemplares similares

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era
por: Palmieri, Maria, et al.
Publicado: (2023)

Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
por: O’Sullivan, Éabha, et al.
Publicado: (2023)

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer
por: Kim, Tae‐Ok, et al.
Publicado: (2018)

Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
por: Pesta, Martin, et al.
Publicado: (2022)

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
por: Calabrese, Fiorella, et al.
Publicado: (2019)

Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
por: Rijavec, Erika, et al.
Publicado: (2019)

Current status and future perspectives of liquid biopsy in non-small cell lung cancer
por: Chang, Sunhee, et al.
Publicado: (2020)

Therapeutic strategies in METex14 skipping mutated non-small cell lung cancer
por: Drusbosky, Leylah M., et al.
Publicado: (2021)

Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC)
por: Sardarabadi, Parvaneh, et al.
Publicado: (2021)

Comparison of small biopsy specimens and surgical specimens for the detection of EGFR mutations and EML4-ALK in non-small-cell lung cancer
por: Xiao, DeSheng, et al.
Publicado: (2016)

Update on liquid biopsy in clinical management of non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Future directions and management of liquid biopsy in non-small cell lung cancer
por: Cossu, Alessia Maria, et al.
Publicado: (2020)

Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
por: Fu, Kai, et al.
Publicado: (2022)

Liquid Biopsy in Non-Small Cell Lung Cancer
por: Molina-Vila, Miguel A., et al.
Publicado: (2016)

Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Jung, Chi Young, et al.
Publicado: (2018)

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
por: Nacchio, Mariantonia, et al.
Publicado: (2020)

Treatment strategy of EGFR-mutated non-small cell lung cancer
por: Tanaka, Fumihiro, et al.
Publicado: (2022)

Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
por: Weber, Britta, et al.
Publicado: (2014)

The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
por: Zhang, Yi-Chen, et al.
Publicado: (2017)

The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
por: Akhoundova, D., et al.
Publicado: (2020)

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
por: Nagasaka, Misako, et al.
Publicado: (2021)

The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2022)

Liquid Biopsy for Guiding Treatment Decisions in Advanced Non–Small Cell Lung Cancer
por: Suk, Gretchen
Publicado: (2022)

Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer
por: Cho, Sun Mi, et al.
Publicado: (2023)

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance
por: Schwartzberg, Lee S., et al.
Publicado: (2020)

Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
por: Bonanno, Laura, et al.
Publicado: (2022)

Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer
por: Fujita, Shiro, et al.
Publicado: (2015)

Resistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic Strategies
por: Koulouris, Andreas, et al.
Publicado: (2022)

Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer
por: Brockley, Liam J., et al.
Publicado: (2023)

Detecting EGFR Mutations in Patients with Non-small Cell Lung Cancer
por: Hammoudeh, ZA, et al.
Publicado: (2018)

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment
por: Filipska, Martyna, et al.
Publicado: (2021)

Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!
por: Durin, Lucile, et al.
Publicado: (2020)

A Novel Liquid Biopsy Strategy to Detect Small Amounts of Cancer Cells Using Cancer-Specific Replication Adenoviruses
por: Takakura, Masahiro, et al.
Publicado: (2020)

Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy
por: Lu, Jun, et al.
Publicado: (2018)

Detection of epidermal growth factor receptor mutations in formalin fixed paraffin embedded biopsies in Malaysian non-small cell lung cancer patients
por: Shi Yeen, Tiffany Ng, et al.
Publicado: (2013)

Strategies targeting angiogenesis in advanced non-small cell lung cancer
por: Wang, Jun, et al.
Publicado: (2017)

Oligometastatic non-small-cell lung cancer: current treatment strategies
por: Richard, Patrick J, et al.
Publicado: (2016)

Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer
por: Nishihara, Shigetoshi, et al.
Publicado: (2022)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients
por: Roldan Ruiz, Jonnathan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ttavjb2rm2t4mnogqstgp72ufp